AMEX · POAS
Healthcare · Medical - Devices
$2.25
Down-$0.30 (-13.33%)
Updated Oct 23, 2026, 5:02 PM
SID Score
3.0/10
Composite research score
Smart Money
—
Institutional and insider signal
Price performance · POAS
1M range · 21 trading sessions · Daily adjusted prices
Prices through Oct 22, 2026
POAS closed at $2.25 after 21 trading sessions, down 10.71% for the selected period.
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 22, 2026 | $2.28 | $2.51 | $2.25 | $2.25 | 21K |
| Oct 21, 2026 | $2.01 | $2.57 | $2.01 | $2.285 | 40.53K |
| Oct 20, 2026 | $2.47 | $2.60 | $2.1567 | $2.4201 | 15.69K |
| Oct 19, 2026 | $2.63 | $2.7144 | $2.5006 | $2.63 | 41.76K |
| Oct 16, 2026 | $2.10 | $3.15 | $2.10 | $2.65 | 904.33K |
| Oct 15, 2026 | $2.36 | $2.4118 | $2.16 | $2.16 | 24.5K |
| Oct 14, 2026 | $2.14 | $2.53 | $2.0101 | $2.43 | 64.2K |
| Oct 13, 2026 | $1.99 | $2.66 | $1.8426 | $2.28 | 274.23K |
| Oct 12, 2026 | $2.12 | $2.17 | $1.8798 | $2.00 | 47.95K |
| Oct 9, 2026 | $2.1765 | $2.22 | $1.98 | $2.07 | 13.39K |
| Oct 8, 2026 | $2.115 | $2.2485 | $2.001 | $2.13 | 14.87K |
| Oct 7, 2026 | $2.298 | $2.3025 | $2.172 | $2.2275 | 8.12K |
| Oct 6, 2026 | $2.40 | $2.40 | $2.2035 | $2.322 | 17.61K |
| Oct 5, 2026 | $2.385 | $2.385 | $1.98 | $2.1735 | 15.94K |
| Oct 2, 2026 | $2.5905 | $2.5905 | $2.025 | $2.10 | 65.54K |
| Oct 1, 2026 | $2.415 | $2.802 | $2.403 | $2.67 | 60.44K |
| Sep 30, 2026 | $2.415 | $2.55 | $2.415 | $2.55 | 6.44K |
| Sep 29, 2026 | $2.454 | $2.502 | $2.4172 | $2.46 | 2.74K |
| Sep 28, 2026 | $2.40 | $2.55 | $2.40 | $2.49 | 11.11K |
| Sep 25, 2026 | $2.415 | $2.55 | $2.40 | $2.52 | 2.08K |
| Sep 24, 2026 | $2.55 | $2.55 | $2.43 | $2.52 | 1.25K |
The latest Smart Investors Daily articles mentioning POAS.
Company
Market Activity
Research & News
POAS research
Company profile and research snapshot.
Phaos Technology Holdings Cayman Ltd is an investment holding company incorporated in the Cayman Islands. Through its subsidiaries, the Company engages in the research, development, manufacturing, and commercialization of advanced optical technologies and products. Leveraging its patented microsphere technology, Phaos enhances the magnification of traditional optical microscopes, enabling visualization beyond the 200nm optical limit at a commercially viable working distance. The Company offers advanced microscopy equipment and parts, along with AI-powered software solutions that complement its hardware to deliver fully integrated microscopy systems. Its technologies serve diverse sectors, including manufacturing, biomedical, and research.
Visit company websiteConsensus and target data currently published for this company.
No generated briefing is available yet.
Benzinga · Oct 20, 2026
Gainers Braze (NASDAQ:BRZE) stock rose 51.5% to $45.51 during Tuesday's regular session. The company's market cap stands at $3.4 billion. Gen Digital Inc. - Contingent Value Rights (NASDAQ:GENVR) stock rose
Yahoo · Oct 16, 2026
SINGAPORE, Oct. 16, 2026 (GLOBE NEWSWIRE) -- Phaos Technology Holdings (Cayman) Limited (NYSE American: POAS) (“Phaos” or “the Company”), an advanced microscopy technology company headquartered in Singapore, announced that it filed its annual report on Form 20-F (the “Annual Report”) for the fiscal year ended April 30, 2026 with the U.S. Securities and Exchange Commission (the “SEC”) on August 31, 2026. The Annual Report, which includes the Company’s audited consolidated financial statements for
Benzinga · Oct 16, 2026
Gainers Exascale Labs Holdings (NASDAQ:XLAB) stock increased by 76.4% to $2.4 during Friday's regular session. The market value of their outstanding shares is at $58.4 million. Phaos Technology Holdings
Benzinga · Oct 2, 2026
Gainers Innoviz Technologies (NASDAQ:INVZ) shares moved upwards by 7.6% to $0.39 during Friday's after-market session. The company's market cap stands at $106.6 million. Socket Mobile (NASDAQ:SCKT) shares rose
Interpretive context generated from the platform’s current data sources.
No results
AI research layers have not been published yet.
The latest Smart Investors Daily articles mentioning POAS.
No results
No recent SID articles mention POAS.
